SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
1 Year Est. Return
+73.47%
AUM
$121M
AUM Growth
-$4.02M
(-3.2%)
Holding
84
Top Buys
| 1 | +$1.62M | |
| 2 | +$1.35M | |
| 3 | +$1.3M | |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.23M |
| 5 |
Medtronic
MDT
|
+$1.06M |
Top Sells
| 1 | +$1.4M | |
| 2 | +$1.38M | |
| 3 | +$1.02M | |
| 4 |
CTNM
Contineum Therapeutics
CTNM
|
+$982K |
| 5 |
Eli Lilly
LLY
|
+$935K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Revolution Medicines
RVMD
$33.2B
| $202K | 0.17% |
+1,830
|
|
||
77
Palisade Bio
PALI
$335M
| $172K | 0.14% |
+88,000
|
|
||
78
AstraZeneca
AZN
$273B
| – | – |
-15,232
|
|
||
|
FOLD
79
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-43,300
|
|
||
80
Madrigal Pharmaceuticals
MDGL
$11.3B
| – | – |
-352
|
|
||
|
VTYX
81
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-96,945
|
|
||
|
LENZ
82
LENZ Therapeutics
LENZ
$220M
| – | – |
-42,500
|
|
||
|
TEM
83
Tempus AI
TEM
$8.53B
| – | – |
-4,500
|
|
||
|
CARL
84
Carlsmed
CARL
$277M
| – | – |
-47,700
|
|